CORD-19:185e78aee848db9cc3a4510619048a6e4acd22cc / 3795-4011 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T20","span":{"begin":0,"end":216},"obj":"Sentence"}],"text":"13 Fever was reported in 20% to 50% of patients following singleagent bleomycin, typically occurring after the first dose, and was observed more frequently in patients with cHL compared with solid organ malignancies."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T20","span":{"begin":0,"end":216},"obj":"Sentence"},{"id":"TextSentencer_T20","span":{"begin":0,"end":216},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"13 Fever was reported in 20% to 50% of patients following singleagent bleomycin, typically occurring after the first dose, and was observed more frequently in patients with cHL compared with solid organ malignancies."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T37","span":{"begin":9,"end":12},"obj":"Disease"},{"id":"T38","span":{"begin":127,"end":130},"obj":"Disease"},{"id":"T39","span":{"begin":173,"end":176},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0009348"}],"text":"13 Fever was reported in 20% to 50% of patients following singleagent bleomycin, typically occurring after the first dose, and was observed more frequently in patients with cHL compared with solid organ malignancies."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T23","span":{"begin":3,"end":8},"obj":"Phenotype"}],"attributes":[{"id":"A23","pred":"hp_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/HP_0001945"}],"text":"13 Fever was reported in 20% to 50% of patients following singleagent bleomycin, typically occurring after the first dose, and was observed more frequently in patients with cHL compared with solid organ malignancies."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2","span":{"begin":197,"end":202},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":"13 Fever was reported in 20% to 50% of patients following singleagent bleomycin, typically occurring after the first dose, and was observed more frequently in patients with cHL compared with solid organ malignancies."}